News
Benefits of AZ vaccine outweigh risks, says MHRA
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that there is a possible link between AstraZeneca’s COVID-19 vaccine and “extremely rare, unlikely to occur blood clots”.